Vimarsana
Biggest News Aggregation in the World

Page 24 - Ohnson Johnson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ohnson Johnson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ohnson Johnson Today - Breaking & Trending Today

Johnson & Johnson will stop manufacturing its talc-based baby powder from 2023. Here's why - Vimarsana News

Johnson & Johnson will stop manufacturing its talc-based baby powder from 2023. Here's why

Johnson & Johnson's announcement comes after thousands of lawsuits were filed against the company by several women who claimed that the talcum-based baby powder contained asbestos and many of them developed several health issues including ovarian cancer.

Bangladesh to administer 7.5m booster and second doses of COVID vaccines on Tuesday - Vimarsana News

Bangladesh to administer 7.5m booster and second doses of COVID vaccines on Tuesday

Bangladesh to administer 7.5m booster and second doses of COVID vaccines on Tuesday

US FDA authorises Novavax COVID vaccine for adults - Vimarsana News

US FDA authorises Novavax COVID vaccine for adults

US FDA authorises Novavax COVID vaccine for adults

JNJ: 5 Durable Stocks to Strengthen Your Portfolio - Vimarsana News

JNJ: 5 Durable Stocks to Strengthen Your Portfolio

Johnson & Johnson(NASDAQ:JNJ): Given the current market turmoil caused due to surging inflation and the Fed’s aggressive interest rate hikes to bring prices down, it could be wise to invest in stocks that do not fluctuate significantly in adverse market conditions. The solid stability of Johnson & Johnson (JNJ), Coca-Cola FEMSA (KOF), Marubeni (MARUY), Novartis (NVS), and Weis Markets (WMK) make them a good choice for your portfolio.

Food and Drug Administration limits use of Johnson & Johnson Janssen vaccines to certain individuals - Vimarsana News

Food and Drug Administration limits use of Johnson & Johnson Janssen vaccines to certain individuals

The U.S. Food and Drug Administration has limited the authorized use of the Johnson & Johnson Janssen COVID-19 vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible.